Investigates how turmeric and fingerroot polysaccharides affect gut microbiota modulation, suggesting implications for functional food applications.
The prebiotic potential of crude polysaccharide extracts from turmeric ( Curcuma longa ; CP-TM) and fingerroot ( Boesenbergia rotunda ; CP-FR) was investigated using galactooligosaccharides (GOS) as a reference. Extracts were characterized for carbohydrate content and assessed for probiotic stimulation, pathogen inhibition, gastrointestinal resistance, and in vitro colonic fermentation with human fecal microbiota. Both CP-TM and CP-FR stimulated lactic acid bacteria growth in a strain-dependent manner and suppressed Escherichia coli and Bacillus cereus . In simulated digestion, CP-TM showed comparatively higher survival of Lactobacillus casei , while CP-FR conferred moderate tolerance. Fermentation analyses showed that both extracts modulated microbial diversity, enriched beneficial taxa such as Phascolarctobacterium and Collinsella , and reduced Proteobacteria expansion. Functional prediction analyses suggested shifts in carbohydrate metabolism and stress-adaptation pathways. CP-TM showed the highest acetate and butyrate levels, while all supplements maintained low phenol and p-cresol. These findings suggest that crude polysaccharide extracts from turmeric and fingerroot may represent promising candidates for functional food applications targeting gut microbiota modulation.
No takes yet. Share an insight, caveat, or question.
La-ongkham et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: